Typhanie Ladrière, Julie Faudemer, Elise Levigoureux, Damien Peyronnet, Cédric Desmonts, & Jonathan Vigne. (2023). Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals. MDPI AG.
Chicago Style (17th ed.) CitationTyphanie Ladrière, Julie Faudemer, Elise Levigoureux, Damien Peyronnet, Cédric Desmonts, and Jonathan Vigne. Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals. MDPI AG, 2023.
MLA (9th ed.) CitationTyphanie Ladrière, et al. Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.